NeuroOne Medical Technologies Corporation
NMTC
$0.80
-$0.01-0.87%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 103.77% | 250.36% | 69.00% | 54.53% | 104.21% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 103.77% | 250.36% | 69.00% | 54.53% | 104.21% |
| Cost of Revenue | 16.94% | 19.90% | -12.64% | -21.50% | -26.56% |
| Gross Profit | 594.43% | 265.48% | 106.79% | 89.99% | 86.67% |
| SG&A Expenses | -7.01% | -6.54% | -2.48% | 1.20% | 4.51% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 200.00% | -- | -- | -- | -- |
| Total Operating Expenses | 54.46% | 6.42% | -23.87% | -26.02% | -23.46% |
| Operating Income | -12.67% | 64.44% | 53.64% | 49.20% | 49.96% |
| Income Before Tax | 5.00% | 70.73% | 55.90% | 48.43% | 46.64% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 5.00% | 70.73% | 55.90% | 48.43% | 46.64% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 5.00% | 70.73% | 55.90% | 48.43% | 46.64% |
| EBIT | -12.67% | 64.44% | 53.64% | 49.20% | 49.96% |
| EBITDA | -13.02% | 65.94% | 54.87% | 50.27% | 51.03% |
| EPS Basic | 38.02% | 83.10% | 67.78% | 61.09% | 61.58% |
| Normalized Basic EPS | 40.23% | 80.96% | 61.55% | 57.03% | 59.61% |
| EPS Diluted | 37.50% | 83.12% | 67.82% | 61.13% | 61.61% |
| Normalized Diluted EPS | 40.23% | 80.96% | 61.55% | 57.03% | 59.61% |
| Average Basic Shares Outstanding | 58.11% | 50.01% | 41.04% | 32.72% | 41.94% |
| Average Diluted Shares Outstanding | 58.05% | 50.05% | 41.08% | 32.77% | 41.99% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |